David Larsen
Stock Analyst at BTIG
(1.95)
# 3,046
Out of 5,165 analysts
108
Total ratings
33.33%
Success rate
-6.07%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Reiterates: Buy | $10 | $4.44 | +125.23% | 5 | Mar 10, 2026 | |
| TOI The Oncology Institute | Reiterates: Buy | $7 | $3.59 | +94.99% | 2 | Mar 9, 2026 | |
| MDLN Medline | Reiterates: Buy | $55 | $42.16 | +30.46% | 2 | Mar 9, 2026 | |
| PGNY Progyny | Maintains: Buy | $35 → $30 | $18.05 | +66.20% | 5 | Mar 5, 2026 | |
| BTSG BrightSpring Health Services | Reiterates: Buy | $55 | $42.10 | +30.64% | 6 | Mar 2, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $8 | $2.83 | +182.69% | 9 | Feb 25, 2026 | |
| HIMS Hims & Hers Health | Downgrades: Neutral | n/a | $24.98 | - | 4 | Feb 24, 2026 | |
| HQY HealthEquity | Maintains: Buy | $130 → $110 | $79.40 | +38.54% | 6 | Feb 17, 2026 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $37 → $40 | $29.81 | +34.18% | 4 | Feb 17, 2026 | |
| DOCS Doximity | Maintains: Buy | $80 → $50 | $24.91 | +100.72% | 3 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $6.58 | +67.17% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $24.80 | +61.29% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.92 | - | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $2.61 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $0.61 | - | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $340 | $186.70 | +82.11% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $8.36 | +79.43% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.17 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $168.43 | +54.37% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.12 | +525.00% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.78 | +800.32% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.09 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.10 | +58.37% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.61 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $5.60 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $216.36 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $941.89 | -83.01% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $74.87 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $74.81 | +13.62% | 3 | Feb 9, 2018 |
LifeMD
Mar 10, 2026
Reiterates: Buy
Price Target: $10
Current: $4.44
Upside: +125.23%
The Oncology Institute
Mar 9, 2026
Reiterates: Buy
Price Target: $7
Current: $3.59
Upside: +94.99%
Medline
Mar 9, 2026
Reiterates: Buy
Price Target: $55
Current: $42.16
Upside: +30.46%
Progyny
Mar 5, 2026
Maintains: Buy
Price Target: $35 → $30
Current: $18.05
Upside: +66.20%
BrightSpring Health Services
Mar 2, 2026
Reiterates: Buy
Price Target: $55
Current: $42.10
Upside: +30.64%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $10 → $8
Current: $2.83
Upside: +182.69%
Hims & Hers Health
Feb 24, 2026
Downgrades: Neutral
Price Target: n/a
Current: $24.98
Upside: -
HealthEquity
Feb 17, 2026
Maintains: Buy
Price Target: $130 → $110
Current: $79.40
Upside: +38.54%
Consensus Cloud Solutions
Feb 17, 2026
Maintains: Buy
Price Target: $37 → $40
Current: $29.81
Upside: +34.18%
Doximity
Feb 6, 2026
Maintains: Buy
Price Target: $80 → $50
Current: $24.91
Upside: +100.72%
Feb 2, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $6.58
Upside: +67.17%
Feb 2, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $24.80
Upside: +61.29%
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $11.92
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.61
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $0.61
Upside: -
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $186.70
Upside: +82.11%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $8.36
Upside: +79.43%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.17
Upside: -
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $168.43
Upside: +54.37%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $1.12
Upside: +525.00%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.78
Upside: +800.32%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $35.09
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $22.10
Upside: +58.37%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $5.61
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $5.60
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $216.36
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $941.89
Upside: -83.01%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $74.87
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $74.81
Upside: +13.62%